Literature DB >> 20150600

Bean amylase inhibitor and other carbohydrate absorption blockers: effects on diabesity and general health.

Harry G Preuss1.   

Abstract

Many believe that excessive intake of refined carbohydrates (CHO) plays a major role in the development of obesity/overweight, type 2 diabetes mellitus and insulin resistance, a collection of events commonly referred to as "diabesity," and have sought natural means to overcome these linked perturbations. As a first approach, planned diets with low portions of refined CHO have become popular. However, these diets do not satisfy everyone; and many are concerned over replacing CHO with more fats. As a second option, addition of soluble fiber to the diet can slow absorption of refined CHO, i.e., lower the glycemic index of foods and overcome or at least ameliorate many of the adverse reactions resulting from increased refined CHO ingestion. Unfortunately, the general public does not favor diets high in fiber content, and various fibers can lead to gastrointestinal problems such as gas and diarrhea. A third choice to favorably influence CHO absorption is to use natural dietary supplements that block or slow CHO absorption in the gastrointestinal tract via inhibiting enzymes necessary for CHO absorption -amylase and alpha-glucosidases. Although a number of natural supplements with anti-amylase activity have been recognized, the most studied and favored one is white kidney bean extract. Animal and human studies clearly show that this agent works in vivo and has clinical utility. This paper reviews many aspects of diabesity and the use of "carb blockers" to prevent and ameliorate the situation. In many respects, carb blockers mimic the beneficial effects of fibers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20150600     DOI: 10.1080/07315724.2009.10719781

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  12 in total

Review 1.  Impact of functional foods on prevention of cardiovascular disease and diabetes.

Authors:  Geeta Sikand; Penny Kris-Etherton; Nancy Mariam Boulos
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

2.  Pulse consumption, satiety, and weight management.

Authors:  Megan A McCrory; Bruce R Hamaker; Jennifer C Lovejoy; Petra E Eichelsdoerfer
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

Review 3.  Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review.

Authors:  Parvin Mirmiran; Zahra Bahadoran; Fereidoun Azizi
Journal:  World J Diabetes       Date:  2014-06-15

Review 4.  A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control.

Authors:  Marilyn L Barrett; Jay K Udani
Journal:  Nutr J       Date:  2011-03-17       Impact factor: 3.271

Review 5.  Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes.

Authors:  James J DiNicolantonio; Jaikrit Bhutani; James H O'Keefe
Journal:  Open Heart       Date:  2015-10-19

Review 6.  Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Open Heart       Date:  2015-01-29

7.  Grain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses.

Authors:  Daniela Lucchesi; Rossella Russo; Morena Gabriele; Vincenzo Longo; Stefano Del Prato; Giuseppe Penno; Laura Pucci
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

8.  Reflection on design and testing of pancreatic alpha-amylase inhibitors: an in silico comparison between rat and rabbit enzyme models.

Authors:  Shiva Khalil-Moghaddam; Azadeh Ebrahim-Habibi; Parvin Pasalar; Parichehreh Yaghmaei; Nasim Hayati-Roodbari
Journal:  Daru       Date:  2012-11-20       Impact factor: 3.117

9.  Subchronic Study of a White Kidney Bean (Phaseolus vulgaris) Extract with α-Amylase Inhibitory Activity.

Authors:  Guangqiu Qin; Fang Wang; Huili Liang; Song Tang; Kamran Shekh; Yanwu Wang; Bin Li; Baiqing Dong; Pingjing Wen
Journal:  Biomed Res Int       Date:  2019-11-22       Impact factor: 3.411

10.  Regular intake of white kidney beans extract (Phaseolus vulgaris L.) induces weight loss compared to placebo in obese human subjects.

Authors:  Shenli Wang; Lishui Chen; Haiying Yang; Jinghan Gu; Jing Wang; Fazheng Ren
Journal:  Food Sci Nutr       Date:  2020-02-05       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.